Document Detail


Intravenous streptokinase and percutaneous transluminal coronary angioplasty in acute myocardial infarction.
MedLine Citation:
PMID:  2963686     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Intravenous streptokinase already has been demonstrated safe and beneficial in acute myocardial infarction. The adjunction of early angiography seems to be safe, providing the possibility of full revascularization in a larger number of patients with a high rate of primary success. The improvement of global ventricular function, the reduction of mortality, post infarction angina and reocclusion have to be confirmed by longer follow-up.
Authors:
R Bonan
Related Documents :
6608636 - Early bypass grafting following intracoronary thrombolysis with streptokinase.
7883296 - Serum magnesium: a prognostic tool of acute myocardial infarction.
12204726 - Intrapericardial fibrinolytic therapy in purulent pericarditis.
4075606 - Intravenous versus intracoronary streptokinase in acute myocardial infarction.
24432186 - Coronary-cameral fistulas in adults: acquired types (second of two parts).
9386086 - Papillary muscle discoordination rather than increased annular area facilitates mitral ...
Publication Detail:
Type:  Clinical Trial; Journal Article; Randomized Controlled Trial    
Journal Detail:
Title:  The Canadian journal of cardiology     Volume:  3 Suppl A     ISSN:  0828-282X     ISO Abbreviation:  Can J Cardiol     Publication Date:  1987 Nov 
Date Detail:
Created Date:  1988-04-07     Completed Date:  1988-04-07     Revised Date:  2008-04-09    
Medline Journal Info:
Nlm Unique ID:  8510280     Medline TA:  Can J Cardiol     Country:  CANADA    
Other Details:
Languages:  eng     Pagination:  30A-33A     Citation Subset:  IM    
Affiliation:
Cardiac Catherterization Laboratory, Montreal Heart Institute, Quebec.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Angioplasty, Balloon*
Clinical Trials as Topic
Humans
Infusions, Intravenous
Myocardial Infarction / drug therapy,  mortality,  therapy*
Random Allocation
Streptokinase / therapeutic use*
Time Factors
Chemical
Reg. No./Substance:
EC 3.4.-/Streptokinase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  On a factor present in tumor cells, capable of decreasing thermotolerance in mice
Next Document:  B-cell lineage acute lymphoblastic leukemia with i(7q) and t(9;9)(p22;p24).